Toggle menu

Julia Grahamslaw

Lead Research Nurse

Research Interests:
Emergency Medicine
Qualifications:
BSc
Twitter:
@emerge_research
Julia Grahamslaw

Julia joined the Emergency Department (ED) in 2008, having started off her nursing career at the Breast unit at the Western General Hospital. Working in the ED was a dream come true; each day brought opportunities to learn something new. It was an exciting and hectic place to work, staffed by highly energetic and spirited individuals. Through the laughs and, at times, the tears, she gained a wealth of knowledge and life-saving skills, and it was with mixed feelings that she embarked upon the next stage of her career, moving to the EMERGE team in 2012.

Emergency research nursing promised a change of scene and a new focus on the academic side of medical care. However, having accepted the job, she decided she had better brush up on her research skills! She duly enrolled on a course in Clinical Research at University, and graduated with a BSc in 2013. In order to retain a balance between the science and the practice, she also completed the Clinical Decision Making module a year later a year later, which she passed with merit.

After settling in to the EMERGE team, working across a number of studies and completing a heart failure audit, Julia became lead co-ordinator for LAVAS and CVLA. After completion of these studies she was asked to present the findings at the Royal College of Nursing International Conference of Research in Nottingham in April 2015. Presently, Julia is co-ordinating the research initiative in the Acute Medical Unit (AMU).

Out of work, she’s on a maniacal mission to become the Bionic Woman, so far, no cigar.


Publication

Grahamslaw, J on behalf of EMERGE. How Research Active are you? Emergency Nurse RCNi. (2015) volume 23 Number 2 page 15

 

Poster presentations

LAVAS and CVLA

• NHS Lothian R&D conference – March 2015.
• RCN International Conference of Research – April 2015.
• Royal College of Emergency Medicine – May 2015


Trials

AKI in LC Study

In the Liver Unit at the Royal Infirmary of Edinburgh, we are involved in research to improve the treatment available for people with liver cirrhosis. Cirrhosis of the liver can make people vulnerable to other potentially serious complications including kidney problems.

Read more

AKI in LC Study

The POP Trial

The study with PP100-01 in combination with NAC is designed to determine safety and tolerability of PP100-01 when co-administered with NAC as compared to the 12-hr NAC treatment regime for patients that come to the hospital after an overdose of paracetamol/acetaminophen.

Read more

The POP Trial

A Randomised Open Label Exploratory, Safety and Tolerability Study with PP100-01 in Patients Treated with the 12-hour Regimen of N-Acetylcysteine for Paracetamol/Acetaminophen Overdose

HighSTEACS Bioresource

Evaluating the kinetics of cardiac biomarkers after ST-segment Elevation myocardial infarction

Read more

HighSTEACS Bioresource

SALI Study

This is a study looking at incidence and risk factors for poor ankle functional recovery, and the development and progression of post-traumatic ankle osteoarthritis after significant ankle ligament injury.

Read more

SALI Study

SALI study - Significant Ankle Ligament Injury

EcLiPSE

This trial is a two arm, multicentre parallel group, randomised controlled, open label trial comparing intravenous levetiracetam to intravenous phenytoin for the treatment of convulsive status epilepticus (CSE) in children, young people and young adults.

Read more

EcLiPSE

Emergency Treatment with Levetiracetam or Phenytoin in Status Epilepticus in Children (EcLiPSE) – an open label randomised controlled trial

IONA

Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.

Read more

IONA

Identification of Novel Psychoactive Substances (IONA)

LAVAS

Determining whether an agreement between peripheral venous and arterial lactate exists in patients presenting to an Emergency Department with sepsis.

Read more

LAVAS

Lactate, Arterial and Venous Agreement in Sepsis

CVLA

Determining the feasibility of a study investigating the agreement between capillary and peripheral venous lactate in the Emergency Department

Read more

CVLA

Capillary and Venous Lactate Agreement

Garfield-VTE

Global Anticoagulant Registry in the FIELD observing treatment and outcomes in patients with treated acute Venous Thromboembolic Events in the real world

Read more

Garfield-VTE

Global Anticoagulant Registry In the FIELD – Venous Thromboembolic Events

TPTIH

The Pharmacogenetics of Thiazide Induced Hyponatraemia

Read more

TPTIH

The Pharmacogenetics of Thiazide Induced Hyponatraemia

Relax 2

Evaluating the efficacy, safety and tolerability of Serelaxin when added to standard therapy in acute heart failure patients (CRLXA).

Read more

Relax 2

Evaluating Serelaxin in acute heart failure patients

ExPRES SEPSIS

To derive a biomarker to allow the identification of patients with confirmed sepsis, and risk stratify patients at risk of developing severe sepsis

Read more

ExPRES SEPSIS

Early Prediction of Severe Sepsis

ENCEPH UK

To produce a predictive tool for HSV encephalitis by comparing those with and without the infection.

Read more

ENCEPH UK

Understanding and improving the outcome in Encephalitis

Halt-It

Tranexamic acid for the treatment of gastrointestinal haemorrhage: an international randomised, double blind placebo controlled trial

Read more

Halt-It

Tranexamic acid for the treatment of gastrointestinal haemorrhage

Related news

Elsie Inglis Award

Elsie Inglis Award

16 Nov 2015 | Julia Grahamslaw

Julia Grahamslaw - Winner Elsie Inglis Award

Read more
A Day in the Life of a Research Nurse

A Day in the Life of a Research Nurse

26 May 2015 | Jen Simpson

Our very own Jen Simpson, takes us through the roller coaster ride that is 24 hours in the shoes of a Research Nurse.

Read more
#WhyWeDoResearch

#WhyWeDoResearch

15 Apr 2015 | Miranda Odam

We asked a number of colleagues and friends why we do what we do. Their answers are inspiring, challenging and sometimes very funny.

Read more